Health experts say the U.S. may be in a “hidden” COVID-19 wave — one much larger than reported data would suggest.
A woman takes a COVID-19 test at a pop-up testing site in New York City, May 3, 2022.are just a fraction of what they were at the peak of the omicron wave.
Although it is clear that infection rates have been steadily rising in recent weeks to their highest reported level since mid-February, scientists acknowledge that it is difficult to know how high COVID-19 case and even hospitalization numbers truly are, given the likely “substantially” undercounting of infections.
Registered nurse Annie Voegele puts on her personal protective equipment gear before treating a COVID-19 patient in their isolation room at the Providence Mission Hospital in Mission Viejo, Calif., April 12, 2022.“We know that the number of infections is actually substantially higher than that. It's hard to know exactly how many but we know that a lot of people are getting diagnosed using home tests,” Jha explained.
Hospitalization numbers have been increasing in recent weeks, but not at a rate as significant as infections. However, Doron said a possible significant surge in infections, without an overwhelming number of hospitalized COVID-19 patients, could be a promising sign.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Biden: Monkeypox threat doesn’t rise to level of COVID-19President Joe Biden is seeking to calm concerns about recent cases of monkeypox that have been identified in Europe and the United States.
Consulte Mais informação »
Pfizer says its COVID-19 vaccine produces a strong immune response in kids under 5A third pediatric dose of the Pfizer-BioNTech COVID-19 vaccine in children 6 months to under 5 years of age prompted a strong immune response, with a safety profile that was similar to placebo, the companies said:
Consulte Mais informação »
Under-five COVID-19 vaccines near finish linePfizer will submit data to the FDA this week.
Consulte Mais informação »
U.S. FDA sets June meeting dates for Moderna, Pfizer small children COVID-19 vaccinesThe U.S. Food and Drug Administration set June 14-15 as the new meeting date to review Moderna Inc's emergency authorization request for its COVID-19 vaccine for children aged 6 months to 5 years and Pfizer Inc's vaccine for those aged 6 months through 4 years.
Consulte Mais informação »
Experts say Texas is ready for latest COVID-19 uptick but advise cautionIt’s still unclear what the increase in cases will mean for the state, but doctors and hospitals say Texas is better prepared to face a surge than before.
Consulte Mais informação »
Biden: Monkeypox threat doesn't rise to level of COVID-19Speaking in Tokyo a day after he said the virus was something “to be concerned about,' Biden said, ”I just don’t think it rises to the level of the kind of concern that existed with COVID-19.'
Consulte Mais informação »